N-Biotinyl-1,6-hexanediaMine

CAS No. 65953-56-2

N-Biotinyl-1,6-hexanediaMine( —— )

Catalog No. M34844 CAS No. 65953-56-2

N-Biotinyl-1,6-hexanediaMine (Biotinyl hexylamine) is a synthetic intermediate that can be used to synthesize nanomedicines and chemotherapeutic couplers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 101 Get Quote
50MG 193 Get Quote
100MG 265 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N-Biotinyl-1,6-hexanediaMine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Biotinyl-1,6-hexanediaMine (Biotinyl hexylamine) is a synthetic intermediate that can be used to synthesize nanomedicines and chemotherapeutic couplers.
  • Description
    N-Biotinyl-1,6-hexanediaMine (Biotinyl hexylamine) is a synthetic intermediate that can be used to synthesize nanomedicines and chemotherapeutic couplers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65953-56-2
  • Formula Weight
    342.5
  • Molecular Formula
    C16H30N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCCC(NCCCCCCN)=O)[C@H]1[C@@]2([C@](CS1)(NC(=O)N2)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • WAY-312858

    WAY-312858 is a chemical agent.

  • Phenazoline

    Argireline a synthetic peptide which is patterned from the N-terminal end of the protein SNAP-25 can both reduce the degree of existing facial wrinkles and demonstrate effectively against their development.

  • Difopein TFA (396834...

    Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.